Ignite Creation Date:
2024-05-06 @ 8:56 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02864914
Status:
COMPLETED
Last Update Posted:
2022-08-03
First Post:
2016-05-13
Brief Title:
Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury Kidney Injury Urinary Tract and Genital Infections and Diabetic Ketoacidosis in Patients Treated With Empagliflozin Compared to DPP-4 Inhibitors
Sponsor:
Organization:
Boehringer Ingelheim
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
99000
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 36400 |
Who Masked List: